- Display 45 Products per page
Published: December 1, 2003 | Price: $1,496.00 – $2,992.00
Severe Acute Respiratory Syndrome (SARS), which was a new and unidentified disease when it first affected people, ripped through Asia and Toronto from late 2002 into the summer of 2003, before being contained for the season. Taiwan with just 346 reported cases performed 10,000 diagnostic tests. Three years after West Nile Virus (WNV) first appeared in the United States in 1999 with just 62 cases and 7 deaths, the U.S. Center for Disease Control reports thousands of cases and 150...Published: April 1, 2004 | Price: $1,995.00 – $3,990.00
The recent terrorism events, in addition to the ease of travel that allows infectious diseases to spread, and technology developments drive the renewed interest in clinical and environmental infectious disease diagnostics. The combined public health and bio-terrorism markets of several bacterial and protozoan diseases are estimated to be nearly $100 million. This report, the final volume of the Diagnostics for Emerging Infectious Disease Threats series, focuses on diagnostic testing for 11 bacterial and protozoal diseases in clinical and environmental testing:...Published: March 1, 2004 | Price: $3,995.00 – $7,990.00
A host of new and old infectious diseases have emerged on the world stage, presenting familiar and novel challenges to public health officials. New strains of once controlled bacteria, new immunocomprimised patient populations, and new bioterror threats have spurred diagnostics companies to develop new tests and kits to meet the demand. Kalorama has assembled the vital data developers and marketers need to understand the competitive and commercial landscape in three volumes: Prion Disease; Viral Disease ; and Baterial & Protozoal...Published: July 24, 2020 | Price: $3,500.00 – $7,000.00
Digital pathology is the technique of analyzing high-resolution digitally scanned histology images, which may then be analyzed using computational tools and algorithms. Digital pathology is enabled in part by virtual microscopy, a method of capturing microscopic images and transmitting them over computer networks. This allows independent viewing of images by large numbers of people in diverse locations. Digital camera equipped microscopes may zoom onto a specific region on a slide to provide higher resolution of the area. In another strategy,...Published: April 1, 2005 | Price: $1,995.00 – $3,990.00
This timely overview of direct to consumer (DTC) pharmaceutical marketing examines the numerous issues surrounding DTC practices and markets, using industry and consumer publications as well as interviews with industry experts. The topics examined include: DTC marketing spending by product, DTC marketing spending by company DTC marketing spending by media channel The ROI debate on the cost-effectiveness of DTC marketing expenditures Arguments for and against DTC marketing by its proponents and critics DTC marketing regulations in the U.S. and selected...Published: January 14, 2019 | Price: $4,500.00 – $9,000.00
Direct-to-Consumer Testing Market With advances in technology, the completion of the sequencing of the human genome and the pressures of capitalism, direct to consumer (DTC) laboratory testing is becoming increasingly popular. The growing market for DTC laboratory testing may promote awareness of health issues and genetic diseases, which could allow patients to take a more proactive role in their healthcare. The global DTC testing market is divided into two distinct areas of DTC testing: Routine clinical laboratory testing Medical genetic...Published: January 14, 2018 | Price: $4,500.00 – $9,000.00
With advances in technology, the completion of the sequencing of the human genome and the pressures of capitalism, direct to consumer (DTC) laboratory testing is becoming increasingly popular. The growing market for DTC laboratory testing may promote awareness of health issues and genetic diseases, which could allow patients to take a more proactive role in their healthcare. The global DTC testing market is divided into two distinct areas of DTC testing: Routine clinical laboratory testing Medical genetic laboratory testing Kalorama’s...Published: March 27, 2018 | Price: $2,995.00 – $5,990.00
In healthcare, there are 27 potential disruptors that could have a large impact on the market. This report discusses them and how they will impact markets in healthcare and pharmaceuticals: • New US Healthcare Policies/ACA Status • Reimbursement Changes in Europe and Other Developed Nations • Brexit • Emerging Countries • Demographic Changes • Ransomware and Blockchain Strategies • Telemedicine • Walk-in Clinics • MACRA • Empowered Consumers • "Gig" Economy • Value-Based Reimbursement • Brazilian Biotech Market •...Published: November 1, 2011 | Price: $150.00 – $300.00
DNA Microarrays are utilized heavily by research labs for a number of tasks such as gene profiling, RNA detection and SNP analysis. But as Kalorama Information's DNA Market Trends report indicates, the market for these systems is about to experience change. The report authored by Kalorama Information biotech analyst Justin Saeks, is the result of surveys carried out with microarray labs to determine the current state of the microarray market and attempt to predict the future direction of the technologies....Published: August 1, 2009 | Price: $3,800.00 – $7,600.00
Since the last edition of Kalorama Information's DNA Sequencing Equipment and Services report, the market has been changing in unpredictable ways as second-generation sequencers are being incrementally introduced and upgraded. On the surface, the situation has become somewhat linear and predictable, but as Kalorama Information biotech analyst Justin Saeks explains, it is actually a unique and relatively volatile situation that is not seen often with life science tools markets. Third-generation systems have the potential to completely change the market, or...Published: October 2, 2018 | Price: $4,500.00 – $9,000.00
Downstream Bioprocessing Markets (Chromatography Columns and Resins, Membrane Adsorbers, Filtration Systems, Sensors) Downstream processing, or bioprocessing, involves the recovery and purification of biosynthetic products, often pharmaceuticals, from natural sources. These sources may be animal or plant tissue or fermentation broth. It is an essential step in producing pharmaceuticals, such as antibiotics, hormones (insulin and human growth hormone), antibodies, and vaccines. Downstream Bioprocessing Markets analyzes the current and potential world market for components used in downstream processing, including the global downstream...Published: February 1, 2007 | Price: $2,995.00 – $4,990.00
Fueled by the promise of needle-free mechanisms for vaccine distribution and other pharmaceutical uses, the implantable/injectable drug delivery market is growing rapidly. The development of better delivery systems in conjunction with the discovery of novel pharmacological compounds will lead to continued growth. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products. The implantable/injectable delivery drug market is a expected to grow to over $12 billion by 2010. Kalorama’s Drug Delivery Markets. Edition...Published: March 1, 2007 | Price: $2,495.00 – $4,990.00
The lungs are considered by many to be the best alternative for drugs needing to bypass the gastrointestinal tract. With advancing technology, the practice of utilizing the huge surface area of the lungs to delivery drugs into the blood circulation has been slowly transforming into reality. The pulmonary drug delivery market reached $25.5 billion in 2006 and is expected to experience high steady growth in the next five years. Contributing to growth are new technologies such as dry powder inhalers...Published: April 1, 2007 | Price: $2,495.00 – $4,990.00
New biological treatments are being developed at a record pace, but their potential could be compromised by a significant obstacle: the delivery of these drugs into the body. Pharmaceutical delivery is now nearly as important as product. Kalorama's Drug Delivery Markets Series covers these new systems. The fourth volume of this series, Kalorama's Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug Delivery is a complete overview of a delivery mechanism that offers some advantages: low pain, infection risk, fewer...Published: September 1, 2009 | Price: $2,995.00 – $5,990.00
With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets. Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. This report looks at that trend and reports...Published: July 1, 2000 | Price: $995.00 – $5,990.00
Since our last edition of this report in 2007, the oral drug delivery market is the largest segment of the drug delivery market, and there’s no sign that it is slowing down. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, and seeking to tap into the growing elderly population that requires products with a level of ease-of-use and cost benefit, it’s no surprise that the oral drug delivery market is a...Published: April 1, 2007 | Price: $4,995.00 – $9,990.00
Novel pharmacological and biological approaches to disease are calling for novel systems of delivering therapies. This has focused attention on the market for drug delivery systems and the pharmaceuticals that are sold along with those technologies. Kalorama's Drug Delivery Systems focuses on these technologies. This offer is for the entire 4 volumes of Kalorama's 2nd edition of its Drug Delivery Markets series, covering all major types, including: Oral Delivery Implantable/Injectable Pulmonary Transdermal/Transmucosal While oral delivery remains the most popular and...Published: November 7, 2003 | Price: $746.00 – $1,492.00
Over the past three years, Kalorama Information's analysts have studied drug delivery markets from several angles. In 2001 and 2002, we published a 5-volume series on drug delivery technology, each volume devoted to a route of administration: Volume I: Oral Drug Delivery Volume II: Injectable and Implantable Drug Delivery Volume III: Pulmonary Drug Delivery Volume IV: Transdermal and Transmucousal Drug Delivery Volume V: Advanced Drug Delivery This series segmented the market by technology and included an innovative analysis that estimated...Published: October 1, 2007 | Price: $995.00 – $1,990.00
It can be said that pharmaceutical companies face a 'new era.' in the coming years. Old strategies will not produce the same results. A wave of generic competition is poised to affect most brands. Drug companies have had to cut research budgets, leading to a dearth of new products on the market. This means there is very little margin for error in the pricing decision. Drug pricing is one of the key levers that determine the profitability of a drug...Published: April 1, 2003 | Price: $1,875.00 – $3,750.00
Each year in the United States, more than 500,000 people with coronary artery disease are treated with percutaneous transluminal coronary angioplasty (PTCA). Unfortunately, restenosis occurs within three to six months in 40% to 50% of PTCA patients due to either thrombosis or abnormal tissue growth. As a result, restenosis constitutes the major limitation to the effectiveness of PTCA. To improve on this condition, medical science created stents in an attempt to keep coronary arteries open. However, one of the early...Published: July 14, 2014 | Price: $995.00 – $1,990.00
Drugs of Abuse is an important growth category in IVD testing with competitive participation by top IVD vendors for market share. Healthcare professionals, employers, criminal justice personnel, and sports use drug tests as part of a comprehensive evaluation of individuals to reach a correct decision regarding the individuals’ actions, behaviors or performances. This report covers trends and markets in drugs of abuse testing. As part of its coverage, the report offers estimates and forecasts for drugs of abuse markets, and...Published: June 1, 2004 | Price: $2,995.00 – $5,990.00
Ten years ago, high throughput screening (HTS) was being touted as the answer to improving productivity in drug discovery. If screening thousands of compounds a week was good, screening hundreds of thousands would be even better. This led to the boom in Ultra HTS (UHTS), manufacturing-scale systems, and high-speed automation. Today, reality has begun to creep in: HTS and UHTS have not lived up to their hype. R&D productivity is not improving, in fact it may be declining. In the...Published: June 1, 2007 | Price: $1,990.00 – $6,990.00
Toxicity is a crucial parameter that is measured throughout the drug development process. Toxic side-effects are one of the most common reasons drug candidates fail. Toxicity can be a factor of dose, the form in which the drug is administered, and the time of exposure before elimination. Patient responses also differ widely, depending on their age and metabolism and other products in the patient’s system may augment the effect of the drug. Just twenty years ago, toxicology was something that...Published: September 12, 2012 | Price: $3,995.00 – $7,990.00
Early toxicology testing is emerging as one of the mostsignificant areas of drug discovery. Toxicity is no longer something that can be left to the development stage, or just a small part of ADMET. Toxicity determinations are an integral part of all aspects of drug discovery & development. This report, Early Toxicology Markets and Approaches, focuses on markets for early toxicology testing services. The objective of this report is to focus the reader’s attention on the issues and opportunities related...Published: November 1, 2008 | Price: $195.00 – $995.00
Often what separates successful marketing from bad is good competitive intelligence. This is true in life sciences as much as other industries. Many companies approach CI in a way that is unplanned, indirect and harmful to their business. But how does one know if they are conducting their company's CI in the best way? If you are trying to determine how to use competitive intelligence better, if you are attempting to judge your efforts compared to companies that have been...Published: February 1, 2010 | Price: $2,500.00 – $5,000.00
Stimulation of muscles and nerves by the use of electrical stimulation, notably TENS and EMS, has long been part of pain management. But recent developments, such as implanted technologies and the small size/low cost systems, have created a pathway for increased usage and revenue growth. The growing approval of these applications by government regulators and insurance carriers have helped boost demand. Since Kalorama Information's last look at this market six years ago, several implanted electrode therapeutic systems have recently emerged...Published: September 1, 2004 | Price: $3,500.00 – $7,000.00
Neural and muscular stimulation by electronic and magnetic means have evolved into a burgeoning product development and commercial fields. For decades, transcutaneous electronic nerve stimulation (TENS) has been a mainstay in the pain relief arsenal. Through the years, as biocompatibility problems were being solved, electrode and sensor implants developed into a multitude of technologies with healthcare applications. The growing approval of these applications by government regulators and the growing acceptance by insurance carriers have driven the market. These techniques have...Published: February 1, 2004 | Price: $3,500.00 – $7,000.00
Immunologic approaches to cancer therapy are not only increasing in reputation and number, but the market for these products is increasingly becoming a reality. Vaccines are in the forefront of this approach to cancer, and the handful of cancer vaccine products currently on the market for bladder, colon, and skin cancer are soon to be joined by many more with indications for more wide-spread forms, including lung, breast, ovarian, prostate, leukemia, and others. This new study from Kalorama discusses the...Published: September 1, 2010 | Price: $1,500.00 – $3,000.00
Kalorama has been researching and examining the development of cancer vaccines for seven years. In April 2010, the cancer vaccine market experienced one of the biggest achievements in the therapeutic vaccine treatment of cancer—the approval of the prostate cancer vaccine PROVENGE (TM). This, in addition to the success of cervical cancer vaccine products, has created a viable market for what was merely a speculative area just one decade ago. Even with achievements for some companies, numerous vaccines with apparently strong...Published: November 1, 2008 | Price: $3,995.00 – $7,990.00
It is the general consensus of scientists that cancer vaccines will become a reality. Overall the cancer treatment market continues to grow and this demand sets the stage for vaccine products. There are several promising vaccines: the propholactic Gardasil has created a pathway for new vaccine products. M-Vax, Ocon-Vax in late stage development and are preparing for regulatory review in the United States, Europe, Canada, or other international regions. Many of the products with potential approval status over the coming...Published: May 27, 2020 | Price: $3,000.00 – $6,000.00
In light of the COVID-19 (coronavirus) pandemic, it is extremely timely to present a report on the status quo in emerging infectious diseases. While the current pandemic is troublesome and has disrupted normal life, it will follow its course and then fade away. Where could the next pandemic or epidemic come from? There are a number of diseases currently tracking as moving from the developed world to the developing world? Kalorama has addressed emerging infectious disease since our first study nine...Published: August 22, 2022 | Price: $0.00 – $10,000.00
The search for the next large-scale emerging disease was on before the COVID-19 pandemic. Respiratory diseases were among those suggested by Kalorama Information and other outlets and medical associations as possibilities for the next threat. The search is constant, and is by no means limited to respiratory epidemics. As the recent monkeypox concern has demonstrated, little-known pathogens can emerge and become large health threats. This necessitates the development of tests at laboratories. For business planners, it’s worthwhile to have a...Published: December 1, 2009 | Price: $1,995.00 – $7,000.00
It was less than one year ago that Kalorama Information surveyed the market for electronic medical records. Yet much has changed and the changes may reach into every aspect of healthcare. Since our last report, the U.S. Government has decided to incentivize the use of EMRs through extra Medicare payments, companies have merged and new players - including some well-known corporate giants, have entered the field. What impact have the announcement of ARRA (stimulus) incentives had, if any? What is...Published: March 1, 2011 | Price: $150.00 – $300.00
For several years Kalorama Information has been studying the trend of electronic medical records (EMR) and electronic health records (EHR). What was already a fast-growing market dramatically changed in 2009 when as part of the ARRA stimulus law, the US Government provided incentives for physicians and hospitals to use systems. Those incentives have now been clarified and in 2011, the first checks have been issued. What will be the impact of those incentives, as well as vendor actions? And what...Published: March 13, 2012 | Price: $2,500.00 – $5,250.00
This report, EMR 2012 is a look at the market and trends impacting electronic medical record software and related services. Included in the report are statistics influencing the industry, demographics; life expectancy, and company strategies. Information is presented as a U.S. market, with a section on key international markets. A market summary includes a total market analysis. Also included is a competitive analysis of leading EMR system providers. As part of its research, the report includes: 2011 Market Estimates for...Published: April 2, 2014 | Price: $995.00 – $1,990.00
The EMR Industry Standard Kalorama has continuously examined the fast-changing market for electronic medical records (EMR) for nearly a decade, and each year we produce a comprehensive report of our findings. Our report has become the industry standard, oft-quoted by companies and industry associations as the source for market sizing and market share in healthcare. This Kalorama Information report, EMR 2014, is a complete global analysis of the EMR market. The report includes the important trends that will affect companies offering software, hardware and services related to EMR....Published: May 1, 2015 | Price: $1,995.00 – $3,995.00
EMR 2015: The Market for Electronic Medical Records This Kalorama Information report, EMR 2015: The Market for Electronic Medical Records, is the resource that electronic medical records (EMR) companies use for business planning, benchmarking, and opportunity analysis. This 490-page report is a complete global analysis of the EMR / EHR market. The eighth annual report concluded on this topic since 2007, EMR 2015 includes the important trends that will affect EMR companies offering software, hardware and services. EMR System Vendors Market Share, Physician...Published: April 13, 2016 | Price: $796.00 – $6,720.00
EMR 2016: The Market for Electronic Medical Records EMR 2016 examines the marketplace and trends affecting electronic medical record (EMR) software and related services. This 499-page contains statistics influencing the business, demographics, life expectancy, and competitor strategies. This total market analysis includes EMR revenue analysis, 2013-2020; revenue share (%) of EMR companies, 2015; hospital EMR revenue estimates: 2013-2020; physician/Web-based EMR revenue estimates: 2013-2020; and sales and market share of EMR manufacturers, 2015. This market review also features EMR revenue analysis...Published: May 7, 2018 | Price: $3,995.00 – $7,990.00
EMR 2018: The Market for Electronic Medical RecordsEMR 2018, now in its Eleventh Edition, provides a trusted source of analysis of the electronic medical records (EMR) industry. The report looks at the market and trends affecting electronic medical record software and related services. Included in the report are statistics influencing the industry, demographics, life expectancy, and company strategies. This 403-page report is a complete global analysis of the EMR / EHR market. A market summary includes a total market analysis,...Published: April 23, 2019 | Price: $5,000.00 – $10,000.00
EMR 2019 represents the twelfth time that Kalorama Information has created a detailed study of the electronic medical records (EMR) industry. The report looks at the market and trends affecting electronic medical record software and related services. Included in the report are statistics influencing the industry, demographics, life expectancy, and company strategies. This 450-page report is a complete global analysis of the EMR / EHR market. A market summary includes a total market analysis, including: EMR Market Analysis 2018-2023 ($...Published: October 15, 2012 | Price: $995.00 – $1,990.00
EMR in Europe This report, EMR Europe 2012 is a look at the market and trends impacting electronic medical record software and related services in Europe. Included in the report are statistics influencing the industry, demographics, and company strategies. A market summary includes a total market analysis. Also included is a snapshot look at individual countries’ demographics, healthcare spending, EMR adoption depth and competitive opportunities. Electronic Medical Records has been established in several European countries for the last decade or...Published: April 18, 2017 | Price: $3,196.00 – $6,392.00
EMR Market 2017: Electronic Medical Records Market in an Era of Disruption For a decade, the EMR market could be said to be growing market on a predictable trajectory. There is a great deal of competition, hundreds of scattered companies serving local or web markets, and a few large concerns that are capturing large institutions. There were government-funded physician and hospital incentives in the largest market of the United States, which transformed to potential penalties. All the while, some trends...Published: August 10, 2012 | Price: $995.00 – $1,990.00
Epigenetics (“Epi”; “over “ or “above” genetics) is recognized as those systems that control the expression of DNA-coded genes, but do not reside in the base pair sequences of the DNA. Rather, these control mechanisms are based on factors or molecules that bind to specific regions of the DNA (the genome), affecting gene expression. The three most important, and best understood mechanisms, are: Methylation, Histone Modulation and Micro RNA (or miRNA) Regulation This report an assessment of commercial outlook for...Published: October 25, 2018 | Price: $1,500.00 – $3,000.00
This brief report contains Kalorama Information's estimates of European in vitro diagnostics markets including current (2018) country level estimates and forecasts. Content for this report is based on information in The Worldwide Market for In Vitro Diagnostic Tests, 11th Edition, with additional forecasting information.Published: January 2, 2018 | Price: $3,995.00 – $7,990.00
European Medical Device MarketsEuropean Medical Device Markets provides market size estimate and forecast to 2022 for the European market and individual country revenues, including Germany, France, UK, Italy, Spain, Sweden, Switzerland, and others; an examination of bellwether device companies; revenues for specific categories of medical devices; a look at market drivers and limiters; and competitive analysis of major device manufacturers.The report looks at the European device market and its trends, including medical device spending as a percentage of European health...